About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients

GLANCE 2 - Glucosamine and Chondroitin (G&C) Effects Study

NCT03827161•Fred Hutchinson Cancer Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Healthy SubjectOverweight

Interventions

Glucosamine

Placebo

Locations

1

United States

Locations (1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

Key Dates

Start Date

August 1, 2017

Primary Completion Date

December 1, 2018

Completion Date

December 1, 2018

Last Updated

February 1, 2019

Related Studies

RECRUITINGPhase 3

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

NCT07351045

Obesity or Overweight

RECRUITINGPhase 1

A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity

NCT07508241

ObesityOverweight and/or Obesity+2 more

Dietary Peanuts and Nutrition-Related Outcomes

NCT07244458

Dietary ChangeObesity & Overweight+1 more

RECRUITINGPhase 2

A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

NCT07395687

OverweightObesity

RECRUITINGPhase 3

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

NCT07311850

Obesity and Overweight

RECRUITINGPhase 4

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

NCT06857942

PsoriasisOverweight or Obesity

View all related studies

Sponsors

Lead Sponsor

Fred Hutchinson Cancer Center

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 1, 2019Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions